The estimation of economic effectiveness of preventive measures of non-infectious diseases

Abstract

ABSTRACT Introduction: The world today is characterized by the globalization of processes affecting social development. The globalization of preventive work today necessarily involves inter-sectorial interaction. Such a huge work with the preventive aim allows to comprehensively influencing the positive effect on the prevention of negative manifestations in the health of both human and the whole population. That means, that we can talk about a preventive strategy, which should be inherent in total character. The Public Health Service should have a state approach. Many countries confirmed this, such as: USA, Sweden, France, Germany, Great Britain, etc. Prevention, in the broadest sense of the word, must take place, of course, both at the local level and at the interregionale one, and if we talk about a global approach, then we also can speak about the international level. The economic effect of such work is clearly demonstrated as a consequence of prophylactic programs on infectious diseases. The aim of this article is to justify the economic effectiveness of the prevention of non-communicable diseases and to determine the criteria for calculating the economic forecast. Materials and methods: The research was conducted with the help of theoretical and statistical methods, by studying scientific sources and systematic analysis and generalization of the experience of finding economic efficiency of preventive measures for non-communicable diseases. Review and conclusions: The analysis of the considered methods of economic evaluation of preventive measures of non-infectious diseases made it possible to draw the following conclusions, the effectiveness of the health care system and individual treatment and prevention institutions should be considered in a complex way from the point of view of medical, social and economic efficiency. Economic efficiency, as a rule, is the result of medical and social efficiency. When calculating the cost-effectiveness of treatment and prevention measures, the whole complex of losses and costs associated with illnesses should be taken into account, in particular: direct costs directly related to prevention and treatment; Indirect losses associated with the illness, due to the unprocessed part of the gross domestic product, paid by sick leave letters.